Shopping Cart
- Remove All
- Your shopping cart is currently empty
Clopimozide (R-29764) acts as a calcium channel antagonist and inhibits [3H] nilandipine binding.Clopimozide is a novel and orally available long-acting antischizophrenic psychostatic compound.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 135 € | In Stock | |
5 mg | 342 € | In Stock | |
10 mg | 503 € | In Stock | |
25 mg | 816 € | In Stock | |
50 mg | 1.121 € | In Stock | |
100 mg | 1.510 € | In Stock | |
500 mg | 3.030 € | In Stock |
Description | Clopimozide (R-29764) acts as a calcium channel antagonist and inhibits [3H] nilandipine binding.Clopimozide is a novel and orally available long-acting antischizophrenic psychostatic compound. |
Targets&IC50 | α1-adrenoceptor:0.25 µM, D2 receptor:0.01 µM, Ca2+ channel:0.017 µM |
In vivo | Clopimozide (5 and 35 mg) in 10 patients' plasma levels were determined with the radio-immunological method. The product exhibited a marked effect on schizophrenic target symptoms (significant at the 0.001 and 0.01 levels), of at least one week's duration, with an absence of sedation and a low degree of extrapyramidal side effects. Clopimozide appears to be particularly suitable for the neuroleptic long-term treatment of compensated schizophrenic patients with insight into their disease.[3] |
Alias | R-29764, R 29764, NSC-335305, NSC335305, NSC 335305 |
Molecular Weight | 495.99 |
Formula | C28H28ClF2N3O |
Cas No. | 53179-12-7 |
Smiles | O=C1N(C=2C(N1)=CC(Cl)=CC2)C3CCN(CCCC(C4=CC=C(F)C=C4)C5=CC=C(F)C=C5)CC3 |
Relative Density. | 1.275g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 4.96 mg/mL (10 mM) | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.